In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence.

In vivo administration of interleukin-2 (IL-2)-secreting tumor cells results in complete protection against persistent infection by Theiler's murine encephalomyelitis virus (TMEV) in susceptible DBA/2 mice. The IL-2-mediated protection was found to depend on the inoculum size as well as the tim...

Full description

Saved in:
Bibliographic Details
Main Authors: Larsson-Sciard, E L, Dethlefs, S, Brahic, M
Format: Artigo
Language:Inglês
Published: 1997
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC191120/
https://ncbi.nlm.nih.gov/pubmed/8985419
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items